Recombinant Human Epo Treatment: Beneficial in Chronic Kidney Disease, Chronic Heart Failure, or Both?: Editorial to: “Correction of Anemia with Erythropoietin in Chronic Kidney Disease (Stage 3 or 4): Effects on Cardiac Performance by Pappas et al.”

Detalles Bibliográficos
Autores principales: Belonje, A. M. S., de Boer, R. A., Voors, A. A.
Formato: Texto
Lenguaje:English
Publicado: Springer US 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243255/
https://www.ncbi.nlm.nih.gov/pubmed/18219567
http://dx.doi.org/10.1007/s10557-008-6079-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243255/
https://www.ncbi.nlm.nih.gov/pubmed/18219567
http://dx.doi.org/10.1007/s10557-008-6079-x

Ejemplares similares